13.09.2016 • NewsDede WillamsLindePraxair

Linde and Praxair End Merger Talks

(c) Linde
(c) Linde

Linde and Praxair have called off talks they confirmed in mid-August about creating a mammoth in the industrial gases sector. Germany-based Linde said its management made the decision to pull out in consensus with shareholder representatives on the supervisory board.  Labour-appointed board members are said to have opposed the deal from the outset.

Despite the strategic rationale for a deal, Linde – which slipped from first to second place in the market with the merger of France’s Air Liquide with Airgas – said that though there was strategic rationale for a merger, discussions with Praxair about details, in particular governance issues, “did not result in a mutual understanding.”

Sources who spoke to the news agency Reuters said the companies had failed to agree where to locate key activities, including R&D, and who would fill the leading management roles. The news agency Bloomberg’s sources said the talks had broken down over the German company’s concerns that jobs and operations would be cut at its Munich headquarters.

Similar to arrangements used by other companies, including drugmakers but also petrochemicals giant LyondellBasell –  which is based in the Netherlands but managed from the US-  the holding for the new entity was planned to be based in Europe, with the operational center in Danbury, Connecticut, in the US.    With the latest potential European-US merger off the table, analysts said that there were few opportunities left for a mega merger in the industrial gases market. Even if US-based Air Products is believed to be open for a deal, the sector is already strongly consolidated.

One analyst told Reuters that a Linde-Praxair deal might have had a good chance of passing antitrust regulation in the US, due to Linde’s greater focus on healthcare in that market, and Praxair’s emphasis on industrial on-site production. Analysts interviewed by Bloomberg were more skeptical.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.